SIC 5122 - Drugs, Drug Proprietaries, And Druggists' Sundries
Establishments primarily engaged in the wholesale distribution of prescription drugs, proprietary drugs, druggists'sundries, and toiletries. Establishments primarily engaged in the wholesale distribution of surgical, dental, and hospital equipment are classified in Industry 5047.
Industry trends:
The industry designated by NAICS 5122, which encompasses drugs, drug proprietaries, and druggists' sundries, is experiencing notable qualitative trends driven by technological advancements, regulatory shifts, and evolving consumer preferences. One significant trend is the increasing integration of artificial intelligence and machine learning in drug discovery and development processes. This technological infusion aims to expedite the identification of promising therapeutic candidates and optimize clinical trial designs, thereby reducing time-to-market and R&D costs. Personalized medicine is another growing trend, as advancements in genomics and biotechnology facilitate the creation of tailored therapies for individual patients based on their genetic profiles. This approach promises improved patient outcomes and has the potential to transform treatment paradigms.
Regulatory environments are also adapting, with a focus on accelerating approval processes, especially for treatments addressing unmet medical needs. The FDA and other regulatory bodies are implementing expedited pathways such as Breakthrough Therapy Designation and Accelerated Approval, allowing for faster access to critical medications. Consumer preferences are shifting towards wellness and preventive healthcare, leading to increased demand for over-the-counter (OTC) products, supplements, and natural remedies. This trend is encouraging pharmaceutical companies to diversify their product portfolios and invest in wellness-related innovations.
Looking ahead, the industry is expected to witness continued growth driven by ongoing advancements in biotechnology and increasing healthcare expenditures globally. Companies that leverage AI, embrace personalized medicine, and adapt to regulatory changes are likely to remain competitive. The rise of telehealth and digital pharmacies may further reshape distribution channels, offering more accessibility and convenience to consumers. Overall, the NAICS 5122 industry is poised for transformative growth, with technology and consumer-centric strategies at the forefront of its evolution.
This industry is comprised of:
Antiseptics-wholesale
Bandages-wholesale
Biologicals and allied products-wholesale
Blood plasma-wholesale
Cosmetics-wholesale
Drug proprietaries-wholesale
Druggists'sundries-wholesale
Drugs-wholesale
Hair preparations-wholesale
Medical rubber goods-wholesale
Medicinals and botanicals-wholesale
Medicine cabinet sundries-wholesale
Patent medicines-wholesale
Perfumes-wholesale
Pharmaceuticals-wholesale
Proprietary (patent) medicines-wholesale
Razor blades-wholesale
Razors, nonelectric-wholesale
Toilet articles-wholesale
Toilet preparations-wholesale
Toilet soap-wholesale
Toothbrushes, except electric-wholesale
Vitamins-wholesale
This report includes the ability to segment your Industry by:
- Region
- Employees
- Net Sales
- Company Age
- Total Assets
- Ownership Type
With iCFO You Get
What Is iCFO?
A review and comparison of financial performance of privately-help companies in specified SIC/NAICS industry segment, using industry standard benchmarks.
Sound Business Analysis
Answers come easily with iCFO. Review ROI, sales per employee, profit margins of the top 10%, top 25% and more, to identify areas of concern and opportunity. Examine what if scenarios and P&L impact of reducing costs or adding revenue.
Your Business’ Health In Minutes
It takes only five minutes to enter your data and produce a concise profile of your company’s fiscal state, including critical business ratios focusing on liquidity, profitability, asset efficiency, and growth.